DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Rini BI, Powles T, Atkins MB. et al.
IMmotion151 Study Group. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet 2019;
393 (10189) 2404-2415
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.